Barclays XPeng · XPEV

Barclays Lowers XPeng Price Target to $17

1 min read Reproduced verbatim
Rating
Underweight
Unchanged
Target
$17
from $20 (−15%)
Outcome
Reached
on March 2, 2026
Barclays and XPeng logos

What the analyst said

Barclays analyst Jiong Shao lowered the price target on XPeng (NYSE: XPEV) to $17.00 (from $20.00) while maintaining an Underweight rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

XPEV trades at $10.24. The 7 analysts who set a target in the last 3 months range from $10 to $22, with a median of $16. This $17 target is 6% above the median.

Since the note XPEV has moved −43% (from $17.82). 12-month window: day 262 of 365, closes on February 19, 2027.

Track record

This call✓ Target reached on March 2, 2026, 11 days after the note.

Firm track recordBarclays: 83% of its 40 targets at least a year old were reached within 12 months (#7 of 26 firms). Accuracy ranking →

Barclays on XPeng

Barclays price targets on XPeng

3 calls from February 19, 2026 to August 25, 2026. The target went from $17 to $14 (−18%). The rating stayed Sell.

Barclays targetXPEV share price
  1. August 25, 2026Target cut from $16 (−13%)Sell$14
  2. March 23, 2026Target cut from $17 (−6%)Sell$16
  3. February 19, 2026 This noteEarliest call shownSell$17
Share

Other analysts on XPeng

JP MorganHold Cut price target −13%, kept rating Oct 26 $10from $11.50 CLSABuy Cut price target, kept rating Oct 23 Goldman SachsBuy Cut price target, kept rating Oct 23 Goldman SachsBuy Cut price target −11%, kept rating Oct 23 $16from $18 JP MorganHold Downgraded Sep 30 HK$45
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.